US20030233083A1 - Port, a container and a method for accessing a port - Google Patents

Port, a container and a method for accessing a port Download PDF

Info

Publication number
US20030233083A1
US20030233083A1 US10/167,795 US16779502A US2003233083A1 US 20030233083 A1 US20030233083 A1 US 20030233083A1 US 16779502 A US16779502 A US 16779502A US 2003233083 A1 US2003233083 A1 US 2003233083A1
Authority
US
United States
Prior art keywords
port
septum
container
cap
housing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/167,795
Other versions
US6994699B2 (en
Inventor
Vincent Houwaert
Denis Motta
Patrick Balteau
Francesco Peluso
Silvano Sforacchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Priority to US10/167,795 priority Critical patent/US6994699B2/en
Assigned to BAXTER INTERNATIONAL INC. reassignment BAXTER INTERNATIONAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SFORACCHI, SILVANO, MOTTA, DENIS, BALTEAU, PATRICK, HOUWAERT, VINCENT, PELUSO, FRANCESCO
Assigned to BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A. reassignment BAXTER INTERNATIONAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAXTER INTERNATIONAL INC.
Assigned to BAXTER INTERNATIONAL, INC. reassignment BAXTER INTERNATIONAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAXTER INTERNATIONAL, INC.
Priority to AU2003237274A priority patent/AU2003237274B2/en
Priority to CNB038135752A priority patent/CN1320875C/en
Priority to PCT/US2003/016835 priority patent/WO2003105748A1/en
Priority to JP2004512657A priority patent/JP2005529685A/en
Priority to BRPI0311694-8A priority patent/BR0311694A/en
Priority to EP03736740A priority patent/EP1515678A1/en
Priority to MXPA04011688A priority patent/MXPA04011688A/en
Priority to CA002486212A priority patent/CA2486212C/en
Priority to EP12188239A priority patent/EP2545893A3/en
Publication of US20030233083A1 publication Critical patent/US20030233083A1/en
Priority to HK06100182.2A priority patent/HK1080353B/en
Publication of US6994699B2 publication Critical patent/US6994699B2/en
Application granted granted Critical
Priority to JP2009126953A priority patent/JP2009189861A/en
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1406Septums, pierceable membranes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/24Medical-surgical bags
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S383/00Flexible bags
    • Y10S383/906Dispensing feature
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S604/00Surgery
    • Y10S604/905Aseptic connectors or couplings, e.g. frangible, piercable

Definitions

  • the present invention generally relates to a medication port, an apparatus and a method for using a medication port for injecting or withdrawing a liquid from a container. More specifically, the present invention relates to a method for the injection or withdrawal of a liquid from a container via a medication port. Additionally, the present invention provides an apparatus and a method that may be used for the intravenous administration of a drug.
  • Liquids are often stored in containers constructed from, for example, flexible plastic or glass, and often contain a solution of saline, dextrose or lactated Ringer's, for example.
  • An intravenous (IV) fluid drip generally connects an administration port located on the container with an artery in the patient. The mixed solution then flows from the administration port, through the IV, and to the bloodstream of the patient.
  • IV intravenous
  • a medication port to inject or withdraw a liquid from a container.
  • a medication port on the container through which a drug and/or other solutions may be administered.
  • a needle or cannula is generally implemented to pierce a septum or membrane within the medication port of the container.
  • Known medication ports are often constructed as one-way valves which allow the addition of a medication to a container.
  • known medication ports are often difficult to maintain in a sterile condition and, therefore, may be unsafe.
  • Bacteria, viruses and/or other harmful substances, for example, dirt may be present on the surface of the septum, membrane or container. As a result, such substances may be inadvertently introduced into the solution.
  • a medication port is constructed or attached to a container either as an up-port or as a side-port.
  • the up-port is generally located at a distal end of the container while the side port is located on a sidewall of the container.
  • septum also referred to as a bung
  • the septum prevents liquid inside of the container from leaving the container. Additionally, the septum reduces the risk of foreign substances from entering the container. Further, known septums often may be pierced by a needle or other object to establish fluid communication with the liquid in the container.
  • a cap is often incorporated with the port to enclose a septum.
  • caps often completely surround the entire opening to the container.
  • known caps are often bulky, expensive and inefficient. For instance, larger caps require more material in production and add weight and/or complexity to the entire apparatus.
  • a need therefore, exists for a medication port as well as an apparatus and a method for injecting or withdrawing a liquid from a container to overcome deficiencies of known ports and apparatus and methods using such a port. Additionally, a need exists for a medication port which allows a liquid to be introduced to a container in a sterile environment.
  • the present invention provides a medication port, an apparatus and a method for using a medication port for injecting or withdrawing a liquid from a container.
  • the container may include a solution to be administered to the patient.
  • the present invention provides for the injection or withdrawal of a liquid from a container via a medication port in an efficient and sterile manner. More specifically, the present invention may be used for the intravenous administration of a drug.
  • the present invention also provides for a container with a medication port for injecting or withdrawing a liquid from a container.
  • an apparatus for injecting or withdrawing a liquid from a container has a housing having an interior defined by peripheral walls extending between a first end and a second end.
  • the port has a septum within the interior at the first end of the housing.
  • the port further has a cap on the first end of the peripheral walls of the housing wherein the cap encloses the first end of the housing and covers the septum.
  • a line of separation is provided between the cap and the peripheral walls of the housing.
  • the port has a lip extending between the peripheral walls and the cap at the first end of the housing.
  • the port has a recess formed in the septum wherein the recess includes a slit.
  • the port has a support ring in the interior of the housing wherein the support ring is between the septum and the second end of the housing.
  • a ring is attached to the cap wherein the ring forms an opening between the ring and the cap.
  • the septum has a tapered exterior wall that is secured in the interior of the housing.
  • the cap has a diameter smaller than a diameter of the septum.
  • the support ring has a diameter greater than a diameter of the septum.
  • a container having peripheral walls defining an interior wherein the interior holds a solution.
  • the container has a port having walls defined between a first end and a second end attached to the wall of the housing having an interior.
  • a septum is provided in the interior of the port.
  • a support ring is provided in the interior of the port wherein the septum is between the support ring and the first end of the port and a cap enclosing the first end of the housing wherein the cap covers the septum.
  • the container has a line of separation between the cap and the first end of the housing.
  • the container has a target area in the septum defined by a recess formed in the septum.
  • the container has a slit in the septum.
  • the container has a port integrally formed with the cap.
  • the container has a ring extending from the first end of the container wherein the ring defines an opening.
  • a method for accessing a container. The method has the steps of: attaching a port having walls defined between a first end and a second end wherein the second end is attached to the wall of the container and further wherein the port has a cap at the first end of the port; securing a septum within the housing; securing a support ring within the housing wherein the septum is between the support ring and the first end of the port; and removing the cap to expose only a portion of the septum.
  • a needle is inserted through the septum.
  • the cap is separated from the port at a line of separation.
  • a ring is pulled having an opening attached to the cap to remove the cap from the port.
  • a recess area is formed in the septum wherein the septum has a slit.
  • the walls of the port have a length between the first end and the second end greater than a combined width of the septum and the support ring.
  • Another advantage of the present invention is to provide a port, a container and a method for accessing a port using a medication port having a target area located under the cap.
  • Yet another advantage of the present invention is to provide a port, a container and a method for accessing a container which is compatible with a range of cannulas or needle gauges and lengths as well as with a range of insulin pens.
  • a still further advantage of the present invention is to provide a port, a container and a method for accessing a container which allows for the port to be located away from an administration port providing simplified accessibility to both ports and/or without interference from the other port.
  • an advantage of the present invention is to provide a port, a container and a method for accessing a container for using a medication port which decreases risk of contamination.
  • an advantage of the present invention is to provide a port, a container and a method for accessing a container having a cap.
  • a still further advantage of the present invention is to provide a port, a container and a method for accessing a container having a rigid housing which reduces risk of cannula or needle sticking.
  • FIG. 1 illustrates a perspective view of a container with having a port in an embodiment of the present invention.
  • FIG. 2 illustrates an exploded isometric view of a port in an embodiment of the present invention.
  • FIG. 3 illustrates a sectional view of a cap on the port in an embodiment of the present invention.
  • FIG. 4 illustrates a sectional view of a user removing a cap of the port in an embodiment of the present invention.
  • FIG. 5 illustrates a sectional view of a needle inserted into the port in an embodiment of the present invention.
  • the present invention generally relates to a port, a container and a method for accessing a container for injecting or withdrawing a liquid from the container. Additionally, the present invention relates to a container having a port. More specifically, the present invention relates to a port, a container and a method for accessing a container to introduce a drug into the port.
  • FIG. 1 generally illustrates a perspective view of a container 1 having a first end 23 and a second end 24 .
  • the container 1 may be peripherally sealed and may have a liquid 5 or other solution in an interior of the container 1 .
  • the container 1 may be constructed of a flexible material, such as a PVC or non-PVC material. Such containers are generally known and, as such, will not be described in further detail herein.
  • the container 1 may have a port 2 having a first end 18 and a second end 19 .
  • the medication port 2 of the present invention may be an up-port or a side port. In the embodiment shown in FIG. 1, the medication port 2 is a side-port.
  • the container 1 is illustrated in a position as is common in actual use. More specifically, the container 1 may be positioned up-right and may have the medication port 2 elevated above an administration port 15 in actual use. Additionally, a strap 12 for, for example, a hook may be provided to hang the container 1 in, for example, an elevated position at or near a patient. When the container 1 is positioned at or near the patient, gravity may force the liquid 5 inside the container 1 through the administration port 15 to the patient.
  • the administration port 15 may be located remotely from the medication port 2 as illustrated in the embodiment shown in FIG. 1.
  • the port 2 may have a housing 3 which may have a wall 25 .
  • the port 2 is a medication port through which a medicament may be added or a solution may be removed from the container 1 .
  • the housing 3 and the wall 25 may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art.
  • the housing 3 may be constructed of rigid polypropylene which may reduce risk of a needle 7 puncturing the wall 25 .
  • the housing 3 may be constructed using gamma-grade materials which are approved to withstand gamma irradiation prior to sterilization as a final stage of the manufacturing process. Gamma-grade materials allow for “pre-sterilization” and reduction in autoclaving exposure time.
  • the wall 25 may be circular.
  • the wall 25 of the housing 3 may have a first end 26 and a second end 27 .
  • the second end 27 of the wall 25 may be integrally formed with the second end 19 of the medication port 2 .
  • the first end 26 of the wall 25 may be integrally formed with a cap 9 wherein the cap 9 may be separated from the first end 26 which will be described in further detail hereinafter.
  • the first end 26 of the wall 25 may also have a lip 39 which protrudes inward toward a center of the housing 3 .
  • the lip 39 may be in contact with a septum 4 .
  • the lip 39 may also secure the septum 4 within the housing 3 by friction, or, alternatively, the septum 4 may be sealed to the lip 39 .
  • the lip 39 of the wall 25 may have an inner circumference 47 and an outer circumference 14 as shown in FIG. 2.
  • the wall 25 may have a height 28 and may have a first circumference 30 at the first end 26 and a second circumference 32 at the second end 27 . Additionally, the first circumference 30 at the first end 26 of the wall 25 may be smaller than the second circumference 32 at the second end 27 of the wall 25 . The smaller circumference 30 at the first end 26 of the wall 25 may result in the wall 25 being tapered. More specifically, a taper 31 may result in the wall 25 tilting inward toward the center of the housing 3 .
  • the septum 4 of the medication port 2 may be located within the wall 25 of the housing 3 . Additionally, the septum 4 may be in contact with an inner wall 50 of the housing 3 as shown in FIG. 3.
  • the septum 4 may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art. Additionally, the septum 4 may be constructed of a polyisoprene material which may allow for the septum 4 to re-seal after puncturing the septum 4 by, for example, the needle 7 .
  • the septum 4 may be circular.
  • the septum 4 may have a height 35 and may have a first circumference 36 and a second circumference 37 .
  • the septum 4 may have a first end 33 and a second end 34 .
  • the first circumference 36 at the first end 33 of the septum 4 may be smaller than the second circumference 37 at the second end 34 .
  • the smaller circumference 36 at the first end 33 may result in the septum 4 being tapered. More specifically, a taper wall 38 may result as shown in FIG. 2 wherein an opening at a top side of the septum 4 is greater than at a center of the septum 4 .
  • the first end 33 of the septum 4 may be in contact with the lip 39 of the wall 25 .
  • the lip 39 may secure the septum 4 in place within the housing 3 and may provide a liquid-tight fit between the septum 4 and the wall 25 of the housing 3 .
  • the septum 4 may also have a target area 16 which may assist a health-care provider or other person with insertion of, for example, the needle 7 into the septum 4 .
  • a cannula or other object may be used to pierce-the septum 4 .
  • the target area 16 may also be colored, for example, red, to contrast with the color, for example, black, of the housing 3 . Use of different colors may result in the target area 16 being more visible and/or distinguishable to the health-care provider or other person.
  • a recess 21 may be located within the target area 16 of the first end 33 of the septum 4 .
  • the recess 21 may assist the health-care provider or other person by providing a reduced resistance location to insert the needle 7 through the septum 4 .
  • the target area 16 may also have a slit 54 instead of, or in addition to, the recess 21 .
  • the recess 21 may be formed by an internal wall 8 in the target area 16 of the septum 4 . More specifically, the wall 8 may have a first circumference 51 at the first end 33 of the septum and a second circumference 52 at a valley 53 within the septum 4 . The first circumference 51 at the first end 33 of the septum 4 may be greater than the second circumference 52 at the valley 53 in the septum 4 . The difference in the circumferences of the internal wall 8 may result in the internal wall 8 being tapered.
  • the health-care provider or other person may puncture the septum 4 to establish fluid communication with the liquid 5 in the container 1 .
  • a support ring 17 may support the septum 4 when an object, for example, the needle, is pressed down upon the septum 4 . As illustrated in FIG. 2, the support ring 17 may resemble, for example, a ring.
  • the support ring 17 may allow pressure to be diverted from the outer periphery of the septum 4 onto the support ring 17 .
  • the septum 4 may be able to withstand a greater pressure with the support ring 17 than without the support ring 17 .
  • the support ring 17 may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art.
  • the support ring 17 may be circular and may have a first outer circumference 44 , a second outer circumference 49 and an inner circumference 45 . Additionally, the support ring 17 may have a first end 40 and a second end 41 . The first outer circumference 44 may be at the first end 40 and a second outer circumference 49 may be at the second end 41 . The first outer circumference 44 may be greater than the second outer circumference 49 . As a result, the support ring 17 may taper downward. More specifically, the support ring 17 may have a taper 48 . The first outer circumference 44 and the second outer circumference 49 of the support ring 17 may be in contact with the inner wall 50 of the housing 3 as shown in FIG. 3.
  • the support ring 17 may also have a height 42 which may be smaller than the height 28 of the wall 25 .
  • the inner circumference 45 of the support ring 17 may form a hollow interior area 43 through which the needle 7 or other object may extend after piercing the septum 4 .
  • the first end 40 of the support ring 17 may be in contact with the second end 34 of the septum 4 . Additionally, the second end 41 of the support ring 17 may be in contact with a lip 13 on the container 1 .
  • the housing 3 may also have a cap 9 that may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art.
  • the cap 9 of the housing 3 may have a cover 11 having a circumference 46 .
  • the cap 9 may also have a ring handle 10 . As illustrated in FIG. 2, the cover 11 and the ring handle 10 may be circular.
  • the ring handle 10 of the cap 9 may have a hollow opening 6 through which a user may insert, for example, a finger or hook.
  • the cover 11 of the cap 9 may also have a line of separation 20 .
  • the line of separation 20 may be a perforation, a score line or other line of weakness formed between the cover 11 and the lip 39 of the wall 25 .
  • the line of separation 20 may be formed at the circumference 46 of the cover 11 . More specifically, the line of separation 20 may provide a circumferential point at which the cover 11 may be removed from a remainder of the housing 3 .
  • the cover 11 may be integrally formed with the ring handle 10 by a connector 22 as generally shown in FIG. 2.
  • the connector 22 may be secured to the cover 11 and the ring handle 10 so that a pulling force may break the line of separation 20 .
  • FIG. 3 illustrates an embodiment of the medication port 2 of the present invention with the cap 9 secured to the wall 25 of the housing 3 . More specifically, FIG. 3 illustrates the medication port 2 prior to removal of the cap 9 .
  • the cap 9 When the cap 9 is on the housing 3 , the cap 9 may protect the septum 4 and may create a sterile environment for the septum 4 by sealing the septum 4 from the surrounding environment. More specifically, when the cap 9 is secured to the wall 25 of the housing 3 , dust, pathogens and other harmful substances may not access the septum 4 located within the housing 3 .
  • the septum 4 when the cap 9 is in the sealed position, the septum 4 may be protected from physical damage.
  • the cap 9 may prevent accidental damage that may otherwise occur to the septum 4 if the septum 4 was unprotected.
  • FIG. 4 illustrates an embodiment of the present invention with the cap 9 of the medication port partially removed.
  • the ring handle 10 of the cap 9 may be lifted by, for example, a finger of a user or a hook.
  • the line of separation 20 may break and may allow the user to remove the cap 9 .
  • the septum 4 may be exposed.
  • the septum 4 may be ready for use through penetration of the septum 4 by, for example, the needle 7 .
  • FIG. 5 illustrates an embodiment of the medication port 2 of the present invention with the cap 9 removed from the wall 25 of the housing 3 .
  • FIG. 5 also illustrates the needle 7 inserted through the septum 4 to provide fluid communication with the liquid 5 inside the interior of the container 1 .
  • the septum 4 may be punctured by the needle 7 or cannula (not shown).
  • the needle 7 or other object may pierce the septum 4 through the target area 16 on the septum 4 .
  • the needle 7 or other object may then pass through the hollow interior 43 of the support ring 17 .
  • liquid may be added or withdrawn to from the container 1 as may be required.

Abstract

A port, a container and a method for accessing a port for injecting or withdrawing a liquid from the container are provided. The port may allow for the administration of, for example, a drug, to a patient and may be located on the container. The port has a septum having a target area. The port also has a support ring in contact with the septum. A cap is provided to protect the septum. The cap has a ring handle and allows for removal and exposure of the target area of the septum. A needle, for example, may be used to penetrate the septum allowing the addition or withdrawal of a liquid or other drug to or from the container.

Description

    BACKGROUND OF THE INVENTION
  • The present invention generally relates to a medication port, an apparatus and a method for using a medication port for injecting or withdrawing a liquid from a container. More specifically, the present invention relates to a method for the injection or withdrawal of a liquid from a container via a medication port. Additionally, the present invention provides an apparatus and a method that may be used for the intravenous administration of a drug. [0001]
  • It is generally known that an individual may require a form of medication. Often, the medication must be administered to the patient intravenously. For example, it may be impractical or impossible to administer medication to the patient when the patient is unconscious. Additionally, administration of the medication to the patient orally may also be difficult in some cases. Further, the patient may require prolonged, constant and/or immediate medication which may only be administered intravenously. Of course, numerous other reasons exist for providing medication to a patient intravenously. [0002]
  • Liquids are often stored in containers constructed from, for example, flexible plastic or glass, and often contain a solution of saline, dextrose or lactated Ringer's, for example. An intravenous (IV) fluid drip generally connects an administration port located on the container with an artery in the patient. The mixed solution then flows from the administration port, through the IV, and to the bloodstream of the patient. [0003]
  • Further, it is generally known to provide a medication port to inject or withdraw a liquid from a container. For example, it is known to provide a medication port on the container through which a drug and/or other solutions may be administered. A needle or cannula is generally implemented to pierce a septum or membrane within the medication port of the container. [0004]
  • Known medication ports are often constructed as one-way valves which allow the addition of a medication to a container. However, known medication ports are often difficult to maintain in a sterile condition and, therefore, may be unsafe. Bacteria, viruses and/or other harmful substances, for example, dirt, may be present on the surface of the septum, membrane or container. As a result, such substances may be inadvertently introduced into the solution. [0005]
  • Typically, a medication port is constructed or attached to a container either as an up-port or as a side-port. The up-port is generally located at a distal end of the container while the side port is located on a sidewall of the container. [0006]
  • It is also generally known to provide a septum, also referred to as a bung, within an opening or port of the container. The septum prevents liquid inside of the container from leaving the container. Additionally, the septum reduces the risk of foreign substances from entering the container. Further, known septums often may be pierced by a needle or other object to establish fluid communication with the liquid in the container. [0007]
  • A cap is often incorporated with the port to enclose a septum. However, caps often completely surround the entire opening to the container. As a result, known caps are often bulky, expensive and inefficient. For instance, larger caps require more material in production and add weight and/or complexity to the entire apparatus. [0008]
  • A need, therefore, exists for a medication port as well as an apparatus and a method for injecting or withdrawing a liquid from a container to overcome deficiencies of known ports and apparatus and methods using such a port. Additionally, a need exists for a medication port which allows a liquid to be introduced to a container in a sterile environment. [0009]
  • SUMMARY OF THE INVENTION
  • The present invention provides a medication port, an apparatus and a method for using a medication port for injecting or withdrawing a liquid from a container. The container may include a solution to be administered to the patient. Additionally, the present invention provides for the injection or withdrawal of a liquid from a container via a medication port in an efficient and sterile manner. More specifically, the present invention may be used for the intravenous administration of a drug. The present invention also provides for a container with a medication port for injecting or withdrawing a liquid from a container. [0010]
  • To this end, in an embodiment of the present invention, an apparatus for injecting or withdrawing a liquid from a container is provided. The port has a housing having an interior defined by peripheral walls extending between a first end and a second end. The port has a septum within the interior at the first end of the housing. The port further has a cap on the first end of the peripheral walls of the housing wherein the cap encloses the first end of the housing and covers the septum. A line of separation is provided between the cap and the peripheral walls of the housing. [0011]
  • In an embodiment, the port has a lip extending between the peripheral walls and the cap at the first end of the housing. [0012]
  • In an embodiment, the port has a recess formed in the septum wherein the recess includes a slit. [0013]
  • In an embodiment, the port has a support ring in the interior of the housing wherein the support ring is between the septum and the second end of the housing. [0014]
  • In an embodiment, a ring is attached to the cap wherein the ring forms an opening between the ring and the cap. [0015]
  • In an embodiment, the septum has a tapered exterior wall that is secured in the interior of the housing. [0016]
  • In an embodiment, the cap has a diameter smaller than a diameter of the septum. [0017]
  • In an embodiment, the support ring has a diameter greater than a diameter of the septum. [0018]
  • In another embodiment, a container is provided having peripheral walls defining an interior wherein the interior holds a solution. The container has a port having walls defined between a first end and a second end attached to the wall of the housing having an interior. A septum is provided in the interior of the port. Further, a support ring is provided in the interior of the port wherein the septum is between the support ring and the first end of the port and a cap enclosing the first end of the housing wherein the cap covers the septum. [0019]
  • In another embodiment, the container has a line of separation between the cap and the first end of the housing. [0020]
  • In another embodiment, the container has a target area in the septum defined by a recess formed in the septum. [0021]
  • In still a further embodiment, the container has a slit in the septum. [0022]
  • In an embodiment, the container has a port integrally formed with the cap. [0023]
  • In an embodiment, the container has a ring extending from the first end of the container wherein the ring defines an opening. [0024]
  • In another embodiment of the present invention, a method is provided for accessing a container. The method has the steps of: attaching a port having walls defined between a first end and a second end wherein the second end is attached to the wall of the container and further wherein the port has a cap at the first end of the port; securing a septum within the housing; securing a support ring within the housing wherein the septum is between the support ring and the first end of the port; and removing the cap to expose only a portion of the septum. [0025]
  • In an embodiment, a needle is inserted through the septum. [0026]
  • In an embodiment, the cap is separated from the port at a line of separation. [0027]
  • In an embodiment, a ring is pulled having an opening attached to the cap to remove the cap from the port. [0028]
  • In an embodiment, a recess area is formed in the septum wherein the septum has a slit. [0029]
  • In an embodiment, the walls of the port have a length between the first end and the second end greater than a combined width of the septum and the support ring. [0030]
  • It is, therefore, an advantage of the present invention to provide a port, a container and a method for accessing a container for the injection or withdrawal of a liquid from a container. [0031]
  • Another advantage of the present invention is to provide a port, a container and a method for accessing a port using a medication port having a target area located under the cap. [0032]
  • Yet another advantage of the present invention is to provide a port, a container and a method for accessing a container which is compatible with a range of cannulas or needle gauges and lengths as well as with a range of insulin pens. [0033]
  • A still further advantage of the present invention is to provide a port, a container and a method for accessing a container which allows for the port to be located away from an administration port providing simplified accessibility to both ports and/or without interference from the other port. [0034]
  • Moreover, an advantage of the present invention is to provide a port, a container and a method for accessing a container for using a medication port which decreases risk of contamination. [0035]
  • And, an advantage of the present invention is to provide a port, a container and a method for accessing a container having a cap. [0036]
  • A still further advantage of the present invention is to provide a port, a container and a method for accessing a container having a rigid housing which reduces risk of cannula or needle sticking. [0037]
  • Additional features and advantages of the present invention are described in, and will be apparent from, the detailed description of the presently preferred embodiments and from the drawings.[0038]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a perspective view of a container with having a port in an embodiment of the present invention. [0039]
  • FIG. 2 illustrates an exploded isometric view of a port in an embodiment of the present invention. [0040]
  • FIG. 3 illustrates a sectional view of a cap on the port in an embodiment of the present invention. [0041]
  • FIG. 4 illustrates a sectional view of a user removing a cap of the port in an embodiment of the present invention. [0042]
  • FIG. 5 illustrates a sectional view of a needle inserted into the port in an embodiment of the present invention.[0043]
  • DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • The present invention generally relates to a port, a container and a method for accessing a container for injecting or withdrawing a liquid from the container. Additionally, the present invention relates to a container having a port. More specifically, the present invention relates to a port, a container and a method for accessing a container to introduce a drug into the port. [0044]
  • Referring now to the drawings wherein like numerals refer to like parts, FIG. 1 generally illustrates a perspective view of a container [0045] 1 having a first end 23 and a second end 24. The container 1 may be peripherally sealed and may have a liquid 5 or other solution in an interior of the container 1. The container 1 may be constructed of a flexible material, such as a PVC or non-PVC material. Such containers are generally known and, as such, will not be described in further detail herein.
  • The container [0046] 1 may have a port 2 having a first end 18 and a second end 19. The medication port 2 of the present invention may be an up-port or a side port. In the embodiment shown in FIG. 1, the medication port 2 is a side-port. The container 1 is illustrated in a position as is common in actual use. More specifically, the container 1 may be positioned up-right and may have the medication port 2 elevated above an administration port 15 in actual use. Additionally, a strap 12 for, for example, a hook may be provided to hang the container 1 in, for example, an elevated position at or near a patient. When the container 1 is positioned at or near the patient, gravity may force the liquid 5 inside the container 1 through the administration port 15 to the patient. Preferably, the administration port 15 may be located remotely from the medication port 2 as illustrated in the embodiment shown in FIG. 1.
  • Referring now to FIG. 2, the [0047] port 2 may have a housing 3 which may have a wall 25. Preferably, the port 2 is a medication port through which a medicament may be added or a solution may be removed from the container 1. The housing 3 and the wall 25 may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art. Additionally, the housing 3 may be constructed of rigid polypropylene which may reduce risk of a needle 7 puncturing the wall 25. Further, the housing 3 may be constructed using gamma-grade materials which are approved to withstand gamma irradiation prior to sterilization as a final stage of the manufacturing process. Gamma-grade materials allow for “pre-sterilization” and reduction in autoclaving exposure time.
  • As illustrated in FIG. 2, the [0048] wall 25 may be circular. The wall 25 of the housing 3 may have a first end 26 and a second end 27. The second end 27 of the wall 25 may be integrally formed with the second end 19 of the medication port 2. Additionally, the first end 26 of the wall 25 may be integrally formed with a cap 9 wherein the cap 9 may be separated from the first end 26 which will be described in further detail hereinafter.
  • The [0049] first end 26 of the wall 25 may also have a lip 39 which protrudes inward toward a center of the housing 3. The lip 39 may be in contact with a septum 4. The lip 39 may also secure the septum 4 within the housing 3 by friction, or, alternatively, the septum 4 may be sealed to the lip 39. The lip 39 of the wall 25 may have an inner circumference 47 and an outer circumference 14 as shown in FIG. 2.
  • The [0050] wall 25 may have a height 28 and may have a first circumference 30 at the first end 26 and a second circumference 32 at the second end 27. Additionally, the first circumference 30 at the first end 26 of the wall 25 may be smaller than the second circumference 32 at the second end 27 of the wall 25. The smaller circumference 30 at the first end 26 of the wall 25 may result in the wall 25 being tapered. More specifically, a taper 31 may result in the wall 25 tilting inward toward the center of the housing 3.
  • The [0051] septum 4 of the medication port 2 may be located within the wall 25 of the housing 3. Additionally, the septum 4 may be in contact with an inner wall 50 of the housing 3 as shown in FIG. 3.
  • The [0052] septum 4 may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art. Additionally, the septum 4 may be constructed of a polyisoprene material which may allow for the septum 4 to re-seal after puncturing the septum 4 by, for example, the needle 7.
  • As illustrated in FIG. 2, the [0053] septum 4 may be circular. The septum 4 may have a height 35 and may have a first circumference 36 and a second circumference 37. Additionally, the septum 4 may have a first end 33 and a second end 34. The first circumference 36 at the first end 33 of the septum 4 may be smaller than the second circumference 37 at the second end 34. The smaller circumference 36 at the first end 33 may result in the septum 4 being tapered. More specifically, a taper wall 38 may result as shown in FIG. 2 wherein an opening at a top side of the septum 4 is greater than at a center of the septum 4.
  • The [0054] first end 33 of the septum 4 may be in contact with the lip 39 of the wall 25. The lip 39 may secure the septum 4 in place within the housing 3 and may provide a liquid-tight fit between the septum 4 and the wall 25 of the housing 3.
  • The [0055] septum 4 may also have a target area 16 which may assist a health-care provider or other person with insertion of, for example, the needle 7 into the septum 4. Of course, a cannula or other object may be used to pierce-the septum 4. The target area 16 may also be colored, for example, red, to contrast with the color, for example, black, of the housing 3. Use of different colors may result in the target area 16 being more visible and/or distinguishable to the health-care provider or other person.
  • As further illustrated in FIG. 2, a [0056] recess 21 may be located within the target area 16 of the first end 33 of the septum 4. The recess 21 may assist the health-care provider or other person by providing a reduced resistance location to insert the needle 7 through the septum 4. The target area 16 may also have a slit 54 instead of, or in addition to, the recess 21.
  • The [0057] recess 21 may be formed by an internal wall 8 in the target area 16 of the septum 4. More specifically, the wall 8 may have a first circumference 51 at the first end 33 of the septum and a second circumference 52 at a valley 53 within the septum 4. The first circumference 51 at the first end 33 of the septum 4 may be greater than the second circumference 52 at the valley 53 in the septum 4. The difference in the circumferences of the internal wall 8 may result in the internal wall 8 being tapered.
  • The health-care provider or other person may puncture the [0058] septum 4 to establish fluid communication with the liquid 5 in the container 1. A support ring 17 may support the septum 4 when an object, for example, the needle, is pressed down upon the septum 4. As illustrated in FIG. 2, the support ring 17 may resemble, for example, a ring.
  • More specifically, when the health-care provider or other person inserts an object through the [0059] septum 4, pressure is created on the septum 4. The support ring 17 may allow pressure to be diverted from the outer periphery of the septum 4 onto the support ring 17. As a result, the septum 4 may be able to withstand a greater pressure with the support ring 17 than without the support ring 17. The support ring 17 may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art.
  • The [0060] support ring 17 may be circular and may have a first outer circumference 44, a second outer circumference 49 and an inner circumference 45. Additionally, the support ring 17 may have a first end 40 and a second end 41. The first outer circumference 44 may be at the first end 40 and a second outer circumference 49 may be at the second end 41. The first outer circumference 44 may be greater than the second outer circumference 49. As a result, the support ring 17 may taper downward. More specifically, the support ring 17 may have a taper 48. The first outer circumference 44 and the second outer circumference 49 of the support ring 17 may be in contact with the inner wall 50 of the housing 3 as shown in FIG. 3.
  • The [0061] support ring 17 may also have a height 42 which may be smaller than the height 28 of the wall 25. The inner circumference 45 of the support ring 17 may form a hollow interior area 43 through which the needle 7 or other object may extend after piercing the septum 4.
  • The [0062] first end 40 of the support ring 17 may be in contact with the second end 34 of the septum 4. Additionally, the second end 41 of the support ring 17 may be in contact with a lip 13 on the container 1.
  • The [0063] housing 3 may also have a cap 9 that may be constructed from, for example, rubber, plastic or any other material generally known to those skilled in the art. The cap 9 of the housing 3 may have a cover 11 having a circumference 46. The cap 9 may also have a ring handle 10. As illustrated in FIG. 2, the cover 11 and the ring handle 10 may be circular. The ring handle 10 of the cap 9 may have a hollow opening 6 through which a user may insert, for example, a finger or hook.
  • The [0064] cover 11 of the cap 9 may also have a line of separation 20. The line of separation 20 may be a perforation, a score line or other line of weakness formed between the cover 11 and the lip 39 of the wall 25. The line of separation 20 may be formed at the circumference 46 of the cover 11. More specifically, the line of separation 20 may provide a circumferential point at which the cover 11 may be removed from a remainder of the housing 3.
  • The [0065] cover 11 may be integrally formed with the ring handle 10 by a connector 22 as generally shown in FIG. 2. The connector 22 may be secured to the cover 11 and the ring handle 10 so that a pulling force may break the line of separation 20.
  • FIG. 3 illustrates an embodiment of the [0066] medication port 2 of the present invention with the cap 9 secured to the wall 25 of the housing 3. More specifically, FIG. 3 illustrates the medication port 2 prior to removal of the cap 9.
  • When the [0067] cap 9 is on the housing 3, the cap 9 may protect the septum 4 and may create a sterile environment for the septum 4 by sealing the septum 4 from the surrounding environment. More specifically, when the cap 9 is secured to the wall 25 of the housing 3, dust, pathogens and other harmful substances may not access the septum 4 located within the housing 3.
  • Additionally, when the [0068] cap 9 is in the sealed position, the septum 4 may be protected from physical damage. The cap 9 may prevent accidental damage that may otherwise occur to the septum 4 if the septum 4 was unprotected.
  • FIG. 4 illustrates an embodiment of the present invention with the [0069] cap 9 of the medication port partially removed. The ring handle 10 of the cap 9 may be lifted by, for example, a finger of a user or a hook. When the user pulls on the ring handle 10, the line of separation 20 may break and may allow the user to remove the cap 9. When the cap 9 is removed, the septum 4 may be exposed. Upon removal of the cap 9, the septum 4 may be ready for use through penetration of the septum 4 by, for example, the needle 7.
  • FIG. 5 illustrates an embodiment of the [0070] medication port 2 of the present invention with the cap 9 removed from the wall 25 of the housing 3. FIG. 5 also illustrates the needle 7 inserted through the septum 4 to provide fluid communication with the liquid 5 inside the interior of the container 1.
  • The [0071] septum 4 may be punctured by the needle 7 or cannula (not shown). The needle 7 or other object may pierce the septum 4 through the target area 16 on the septum 4. The needle 7 or other object may then pass through the hollow interior 43 of the support ring 17. After the needle or other object is inserted into the container 1, liquid may be added or withdrawn to from the container 1 as may be required.
  • It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the spirit and scope of the present invention and without diminishing its attendant advantages. It is, therefore, intended that such changes and modifications be covered by the appended claims. [0072]

Claims (20)

We claim:
1. A port comprising:
a housing having an interior defined by peripheral walls extending between a first end and a second end;
a septum within the interior at the first end of the housing;
a cap on the first end of the peripheral walls of the housing wherein the cap encloses the first end of the housing and covers the septum; and
a line of separation between the cap and the peripheral walls of the housing.
2. The medication port of claim 1 further comprising:
a lip extending between the peripheral walls and the cap at the first end of the housing.
3. The medication port of claim 1 further comprising:
a recess formed in the septum wherein the recess includes a slit.
4. The medication port of claim 1 further comprising:
a support ring in the interior of the housing wherein the support ring is between the septum and the second end of the housing.
5. The medication port of claim 1 further comprising:
a ring attached to the cap wherein the ring forms an opening between the ring and the cap.
6. The medication port of claim 1 wherein the septum has a tapered exterior wall that is secured in the interior of the housing.
7. The medication port of claim 1 wherein the cap has a diameter smaller than a diameter of the septum.
8. The medication port of claim 4 wherein the support ring has a diameter greater than a diameter of the septum.
9. A container comprising:
peripheral walls defining an interior wherein the interior holds a solution;
a port having walls defining an interior between a first end and a second end wherein the port is attached to the wall of the housing;
a septum in the interior of the port;
a support ring in the interior of the port wherein the septum is between the support ring and the first end of the port; and
a cap enclosing the first end of the housing wherein the cap covers the septum.
10. The container of claim 9 further comprising:
a line of separation between the cap and the first end of the housing.
11. The container of claim 9 further comprising:
a target area in the septum defined by a recess formed in the septum.
12. The container of claim 9 further comprising:
a slit in the septum.
13. The container of claim 9 wherein the port is integrally formed with the cap.
14. The container of claim 9 further comprising:
a ring extending from the first end of the container wherein the ring defines an opening.
15. A method for accessing a container wherein the container has walls defining an interior, the method comprising the steps of:
attaching a port having walls defined between a first end and a second end wherein the second end is attached to the wall of the container and further wherein the port has a cap at the first end of the port;
securing a septum within the housing;
securing a support ring within the housing wherein the septum is between the support ring and the first end of the port;
removing the cap to expose only a portion of the septum.
16. The method of claim 15 further comprising the step of:
inserting a needle through the septum.
17. The method of claim 15 further comprising the step of:
separating the cap from the port at a line of separation.
18. The method of claim 15 further comprising the step of:
pulling a ring having an opening attached to the cap to remove the cap from the port.
19. The method of claim 15 further comprising the step of:
forming a recessed area in the septum wherein the septum has a slit.
20. The method of claim 15 wherein the walls of the port have a length between the first end and the second end greater than a combined width of the septum and the support ring.
US10/167,795 2002-06-12 2002-06-12 Port, a container and a method for accessing a port Expired - Fee Related US6994699B2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
US10/167,795 US6994699B2 (en) 2002-06-12 2002-06-12 Port, a container and a method for accessing a port
EP12188239A EP2545893A3 (en) 2002-06-12 2003-05-28 Container comprising a port
CNB038135752A CN1320875C (en) 2002-06-12 2003-05-28 A port, a container and a method for accessing a port
EP03736740A EP1515678A1 (en) 2002-06-12 2003-05-28 A port, a container and a method for accessing a port
CA002486212A CA2486212C (en) 2002-06-12 2003-05-28 A port, a container and a method for accessing a port
PCT/US2003/016835 WO2003105748A1 (en) 2002-06-12 2003-05-28 A port, a container and a method for accessing a port
JP2004512657A JP2005529685A (en) 2002-06-12 2003-05-28 Port, container and how to access the port
BRPI0311694-8A BR0311694A (en) 2002-06-12 2003-05-28 hole, container, and method for accessing a hole
AU2003237274A AU2003237274B2 (en) 2002-06-12 2003-05-28 A port, a container and a method for accessing a port
MXPA04011688A MXPA04011688A (en) 2002-06-12 2003-05-28 A port, a container and a method for accessing a port.
HK06100182.2A HK1080353B (en) 2002-06-12 2006-01-05 A port, a container and a method for accessing a port
JP2009126953A JP2009189861A (en) 2002-06-12 2009-05-26 Port, container and method for accessing port

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/167,795 US6994699B2 (en) 2002-06-12 2002-06-12 Port, a container and a method for accessing a port

Publications (2)

Publication Number Publication Date
US20030233083A1 true US20030233083A1 (en) 2003-12-18
US6994699B2 US6994699B2 (en) 2006-02-07

Family

ID=29732255

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/167,795 Expired - Fee Related US6994699B2 (en) 2002-06-12 2002-06-12 Port, a container and a method for accessing a port

Country Status (10)

Country Link
US (1) US6994699B2 (en)
EP (2) EP1515678A1 (en)
JP (2) JP2005529685A (en)
CN (1) CN1320875C (en)
AU (1) AU2003237274B2 (en)
BR (1) BR0311694A (en)
CA (1) CA2486212C (en)
HK (1) HK1080353B (en)
MX (1) MXPA04011688A (en)
WO (1) WO2003105748A1 (en)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006042579A1 (en) * 2004-10-20 2006-04-27 Fresenius Kabi Deutschland Gmbh Closing cap for containers filled with medical liquids
WO2009038505A1 (en) * 2007-09-17 2009-03-26 Carmel Pharma Ab Bag connector
US20090105684A1 (en) * 2007-10-23 2009-04-23 Baxter International Inc. Medication port for medical fluid container
US7770611B2 (en) 1999-11-12 2010-08-10 Baxter International Inc. Peelable seal closure assembly
US20100237163A1 (en) * 2009-03-23 2010-09-23 Cabochon Aesthetics, Inc. Bubble generator having disposable bubble cartridges
US7867215B2 (en) 2002-04-17 2011-01-11 Carmel Pharma Ab Method and device for fluid transfer in an infusion system
USD637713S1 (en) 2009-11-20 2011-05-10 Carmel Pharma Ab Medical device adaptor
US7942860B2 (en) 2007-03-16 2011-05-17 Carmel Pharma Ab Piercing member protection device
US7975733B2 (en) 2007-05-08 2011-07-12 Carmel Pharma Ab Fluid transfer device
US8029747B2 (en) 2007-06-13 2011-10-04 Carmel Pharma Ab Pressure equalizing device, receptacle and method
US8075550B2 (en) 2008-07-01 2011-12-13 Carmel Pharma Ab Piercing member protection device
US8162013B2 (en) 2010-05-21 2012-04-24 Tobias Rosenquist Connectors for fluid containers
US8287513B2 (en) 2007-09-11 2012-10-16 Carmel Pharma Ab Piercing member protection device
US8328772B2 (en) 2003-01-21 2012-12-11 Carmel Pharma Ab Needle for penetrating a membrane
US8480646B2 (en) 2009-11-20 2013-07-09 Carmel Pharma Ab Medical device connector
US8523838B2 (en) 2008-12-15 2013-09-03 Carmel Pharma Ab Connector device
US8545475B2 (en) 2002-07-09 2013-10-01 Carmel Pharma Ab Coupling component for transmitting medical substances
US8562583B2 (en) 2002-03-26 2013-10-22 Carmel Pharma Ab Method and assembly for fluid transfer and drug containment in an infusion system
US8622985B2 (en) 2007-06-13 2014-01-07 Carmel Pharma Ab Arrangement for use with a medical device
US8657803B2 (en) 2007-06-13 2014-02-25 Carmel Pharma Ab Device for providing fluid to a receptacle
US8790330B2 (en) 2008-12-15 2014-07-29 Carmel Pharma Ab Connection arrangement and method for connecting a medical device to the improved connection arrangement
US8894678B2 (en) 2009-08-07 2014-11-25 Ulthera, Inc. Cellulite treatment methods
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
US9039722B2 (en) 2007-10-09 2015-05-26 Ulthera, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
US9168203B2 (en) 2010-05-21 2015-10-27 Carmel Pharma Ab Connectors for fluid containers
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US9272124B2 (en) 2005-12-02 2016-03-01 Ulthera, Inc. Systems and devices for selective cell lysis and methods of using same
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
RU176559U1 (en) * 2017-05-29 2018-01-23 Иностранное производственное унитарное предприятие "АЛКОПАК" Cap for containers filled with medical fluids
US10398834B2 (en) 2007-08-30 2019-09-03 Carmel Pharma Ab Device, sealing member and fluid container
CN110664019A (en) * 2015-02-13 2020-01-10 方特慕控股第一私人有限公司 Filling system for an electronic smoking device
US10531888B2 (en) 2009-08-07 2020-01-14 Ulthera, Inc. Methods for efficiently reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
WO2020038811A1 (en) * 2018-08-22 2020-02-27 Sartorius Stedim Biotech Gmbh Disposable port device for connecting a functional unit to a flexible wall of a disposable container and method of manufacturing a disposable port device
EP1721595B2 (en) 2005-05-13 2021-08-11 B. Braun Avitum AG Container for providing medical fluids
US20210251428A1 (en) * 2016-12-16 2021-08-19 Steven Pippin Apparatus and method for introducing a liquid into a sealed food package
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US11291805B2 (en) 2017-02-10 2022-04-05 Terumo Kabushiki Kaisha Medical elongated body and medical elongated body set
CN114430701A (en) * 2019-09-23 2022-05-03 塞弗德公司 Multi-chamber lid device with reagent ports
US11337725B2 (en) 2009-08-07 2022-05-24 Ulthera, Inc. Handpieces for tissue treatment

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1990092B1 (en) 2001-03-09 2010-02-10 Gen-Probe Incorporated Penetrable cap
US6994699B2 (en) 2002-06-12 2006-02-07 Baxter International Inc. Port, a container and a method for accessing a port
FR2877643B1 (en) * 2004-11-09 2007-02-09 L C 2 Entpr Unipersonnelle A R DEVICE FOR OPENING AND / OR CLOSING A HERMETIC PACKAGING, PARTICULARLY FOR PRESERVING AGRO-FOOD PRODUCTS
TW200808293A (en) * 2006-04-25 2008-02-16 Naigai Kasei Co Ltd A medical cap and a producing method thereof
US20080077116A1 (en) * 2006-09-12 2008-03-27 Rosemary Dailey Container for intravenous fluids
US8387811B2 (en) * 2007-04-16 2013-03-05 Bd Diagnostics Pierceable cap having piercing extensions
US8387810B2 (en) 2007-04-16 2013-03-05 Becton, Dickinson And Company Pierceable cap having piercing extensions for a sample container
US7988026B2 (en) * 2007-09-06 2011-08-02 Cardica, Inc. Endocutter with staple feed
US20090234317A1 (en) 2008-03-13 2009-09-17 Navarro Lissa M Flexible, flat pouch with port for mixing and delivering powder-liquid mixture
GB0816262D0 (en) * 2008-09-05 2008-10-15 Univ Cardiff Surgical manipulator
US20100247824A1 (en) * 2009-03-24 2010-09-30 Baxter International Inc. Non-pvc films having peel seal layer
US8231598B2 (en) * 2009-10-30 2012-07-31 Palyon Medical (Bvi) Limited Propellant bag improvement
US8636693B2 (en) * 2011-04-27 2014-01-28 Palyon Medical Corporation Propellant pillow
DK3357830T3 (en) 2011-06-22 2019-10-07 Sartorius Stedim North America Inc CONTAINER CLOSING AND PROCEDURE FOR PRODUCING THE SAME
US9376305B2 (en) * 2011-06-22 2016-06-28 Allpure Technologies, Inc. Fluid transfer interface
US10773863B2 (en) 2011-06-22 2020-09-15 Sartorius Stedim North America Inc. Vessel closures and methods for using and manufacturing same
WO2015084388A1 (en) 2013-12-06 2015-06-11 Allpure Technologies, Inc. Fluid transfer interface
CN102499887B (en) * 2011-10-28 2014-07-09 湖南千山制药机械股份有限公司 Transfusion soft bag
MX2015003147A (en) 2012-09-11 2015-12-16 Baxter Int Polymer films containing microspheres.
EP3427007B1 (en) * 2016-03-10 2021-11-10 Defelsko Corporation Method and system for testing surfaces for contaminants
ES2675824B1 (en) * 2017-01-12 2019-04-29 Biotechnology Inst I Mas D Sl CONTAINER DEVICE FOR THE COLLECTION, STORAGE AND PROCESSING OF BLOOD OR A BLOOD COMPOUND
US11691866B2 (en) 2017-11-14 2023-07-04 Sartorius Stedim North America Inc. System for simultaneous distribution of fluid to multiple vessels and method of using the same
US11319201B2 (en) 2019-07-23 2022-05-03 Sartorius Stedim North America Inc. System for simultaneous filling of multiple containers
US11577953B2 (en) 2017-11-14 2023-02-14 Sartorius Stedim North America, Inc. System for simultaneous distribution of fluid to multiple vessels and method of using the same
CA3163336A1 (en) * 2019-12-12 2021-06-17 Fresenius Medical Care Holdings, Inc. An injection port for connecting with a medical fluid container and methods for the production of same

Citations (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030955A (en) * 1956-10-08 1962-04-24 Baxter Don Inc Plastic container
US3900028A (en) * 1974-02-26 1975-08-19 American Hospital Supply Corp Injection site for sterile medical liquid container
US3915212A (en) * 1973-12-10 1975-10-28 Abbott Lab Flexible medical fluid container having a combined fill and administration port and reinforced hanger
US3994412A (en) * 1976-03-11 1976-11-30 Abbott Laboratories Tamperproof breakaway port
US4187893A (en) * 1978-07-19 1980-02-12 Abbott Laboratories Combined additive and administration port for a container
US4303067A (en) * 1980-01-21 1981-12-01 American Hospital Supply Corporation Medical liquid bag having an improved additive port
US4307766A (en) * 1979-05-18 1981-12-29 Terumo Corporation Plastic container for medical liquid
US4464178A (en) * 1981-11-25 1984-08-07 Dalton Michael J Method and apparatus for administration of fluids
US4479989A (en) * 1982-12-02 1984-10-30 Cutter Laboratories, Inc. Flexible container material
US4484916A (en) * 1982-01-20 1984-11-27 American Hospital Supply Corporation Medical solution container and port construction
US4592092A (en) * 1982-01-20 1986-05-27 American Hospital Supply Corporation Medical solution container and port construction therefor
US4632673A (en) * 1983-06-15 1986-12-30 Hantaaki Oy Pierceable port for containers
US4636204A (en) * 1982-04-13 1987-01-13 Gambro Lundia Ab Coupling for the connection of flexible tubes and the like
US4675019A (en) * 1984-10-29 1987-06-23 Bellhouse Medical Products Limited Blood monitoring system
US4757911A (en) * 1985-12-09 1988-07-19 Abbott Laboratories Container and closure construction
US4911708A (en) * 1987-05-18 1990-03-27 Otsuka Pharmaceutical Factory, Inc. Self-supportable parenteral bottle of synthetic resin
US4985033A (en) * 1989-05-12 1991-01-15 Richard Wolf Gmbh Apparatus for fixing fascial holding sutures in open laparoscopy
US5061263A (en) * 1989-02-13 1991-10-29 Terumo Kabushiki Kaisha Liquid collection tube
US5104379A (en) * 1989-04-03 1992-04-14 Olympus Optical Co., Ltd. Medical instrument and valve to be mounted on a mount piece of that instrument
US5137529A (en) * 1990-02-20 1992-08-11 Pudenz-Schulte Medical Research Corporation Injection port
US5178607A (en) * 1987-07-31 1993-01-12 Lynn Lawrence A Blood aspiration assembly septum and blunt needle aspirator
US5211634A (en) * 1991-08-06 1993-05-18 Vaillancourt Vincent L Composite seal structure and a coupling arrangement for a cannula
US5211638A (en) * 1988-01-25 1993-05-18 Baxter International Inc. Pre-slit injection site
US5303838A (en) * 1992-09-30 1994-04-19 Portola Packaging, Inc. Frangible fitment for container
US5342316A (en) * 1991-02-14 1994-08-30 Wallace Henry G Resealable sampling port
US5395365A (en) * 1993-03-22 1995-03-07 Automatic Liquid Packaging, Inc. Container with pierceable and/or collapsible features
US5405333A (en) * 1992-12-28 1995-04-11 Richmond; Frank M. Liquid medicament bag with needleless connector fitting using boat assembly
US5425528A (en) * 1991-10-18 1995-06-20 Vetrisystems, Inc. Fluid dispensing apparatus
US5433716A (en) * 1992-05-13 1995-07-18 Heisenberg Finance S.A. Safety closing device for biological liquid containers
US5490848A (en) * 1991-01-29 1996-02-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration System for creating on site, remote from a sterile environment, parenteral solutions
US5540674A (en) * 1993-09-28 1996-07-30 Abbott Laboratories Solution container with dual use access port
US5611792A (en) * 1992-04-12 1997-03-18 Dicamed Ab Value device for aseptic injection and removal of a medical fluid into/from a container
US5637107A (en) * 1994-12-29 1997-06-10 Vaillancourt; Vincent L. Sterilized vial closure and a sterilized parenteral vial
US5685845A (en) * 1995-07-11 1997-11-11 Becton, Dickinson And Company Sterile resealable vial connector assembly
US5718682A (en) * 1996-06-28 1998-02-17 United States Surgical Corporation Access port device and method of manufacture
US6090282A (en) * 1997-02-17 2000-07-18 Claber S.P.A. Filtering element for hose fittings of irrigation system, in particular but not exclusively for garden or kitchen garden
US6113583A (en) * 1998-09-15 2000-09-05 Baxter International Inc. Vial connecting device for a sliding reconstitution device for a diluent container
US6129228A (en) * 1995-01-30 2000-10-10 Portola Packaging, Inc. Apparatus and method for transporting fitment and fitment therefor
US6200300B1 (en) * 1998-11-18 2001-03-13 David S. Smith Packaging Limited Hangable container
US6234335B1 (en) * 1994-12-05 2001-05-22 Integrated Liner Technologies Inc. Sealable container and open top cap with directly bonded elastomer septum
US6287293B1 (en) * 1999-09-28 2001-09-11 C. R. Bard, Inc. Method and apparatus for locating the injection point of an implanted medical device
US6426046B1 (en) * 1997-12-08 2002-07-30 Mettler-Toledo Myriad, Ltd. Chemical vessel cap

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2716447A1 (en) * 1977-04-14 1978-10-19 Faensen Kleinmetall Plastics vessel mouthpiece protective cap - has plastics sealing discs bearing against rubber disc to prevent deposition of water droplets
DE7832028U1 (en) 1978-10-27 1979-04-19 Biotest-Serum-Institut Gmbh, 6000 Frankfurt CLOSURE FOR A PLASTIC INFUSION BAG
JPS61232851A (en) * 1985-04-10 1986-10-17 東洋製罐株式会社 Stopcock for easily openable plastic infusion container excellent in durability
JPH0510822Y2 (en) * 1988-05-23 1993-03-17
DE4327845C2 (en) 1993-08-19 1995-06-29 Matthias Faensen Gmbh & Co Kg Closure for a container
IT1276525B1 (en) 1994-04-13 1997-10-31 Webcraft Technologies Inc DEVICE AND PROCEDURE FOR THE SELECTIVE EXPOSURE OF MICRO-ENCAPSULATED LIQUIDS.
ES2145918T3 (en) 1994-08-03 2000-07-16 Abbott Lab CLOSING PLUG WITH A PARTIAL PERFORATION, PROCEDURE AND DEVICE FOR CREATING A PARTIAL PERFORATION IN SUCH PLUG.
FI101768B (en) 1995-02-02 1998-08-31 Orion Yhtymae Oy A connecting element to an infusion bag
DE10030474C1 (en) 2000-06-21 2002-02-21 Fresenius Kabi De Gmbh Connector for infusion or transfusion bag comprises cylindrical connection piece closed by self-sealing septum and with catches positioned diametrically opposite each which are biased outwards at base by flexible strips
US6994699B2 (en) 2002-06-12 2006-02-07 Baxter International Inc. Port, a container and a method for accessing a port

Patent Citations (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030955A (en) * 1956-10-08 1962-04-24 Baxter Don Inc Plastic container
US3915212A (en) * 1973-12-10 1975-10-28 Abbott Lab Flexible medical fluid container having a combined fill and administration port and reinforced hanger
US3900028A (en) * 1974-02-26 1975-08-19 American Hospital Supply Corp Injection site for sterile medical liquid container
US3994412A (en) * 1976-03-11 1976-11-30 Abbott Laboratories Tamperproof breakaway port
US4187893A (en) * 1978-07-19 1980-02-12 Abbott Laboratories Combined additive and administration port for a container
US4307766A (en) * 1979-05-18 1981-12-29 Terumo Corporation Plastic container for medical liquid
US4303067A (en) * 1980-01-21 1981-12-01 American Hospital Supply Corporation Medical liquid bag having an improved additive port
US4464178A (en) * 1981-11-25 1984-08-07 Dalton Michael J Method and apparatus for administration of fluids
US4592092A (en) * 1982-01-20 1986-05-27 American Hospital Supply Corporation Medical solution container and port construction therefor
US4484916A (en) * 1982-01-20 1984-11-27 American Hospital Supply Corporation Medical solution container and port construction
US4636204A (en) * 1982-04-13 1987-01-13 Gambro Lundia Ab Coupling for the connection of flexible tubes and the like
US4479989A (en) * 1982-12-02 1984-10-30 Cutter Laboratories, Inc. Flexible container material
US4632673A (en) * 1983-06-15 1986-12-30 Hantaaki Oy Pierceable port for containers
US4675019A (en) * 1984-10-29 1987-06-23 Bellhouse Medical Products Limited Blood monitoring system
US4757911A (en) * 1985-12-09 1988-07-19 Abbott Laboratories Container and closure construction
US4911708A (en) * 1987-05-18 1990-03-27 Otsuka Pharmaceutical Factory, Inc. Self-supportable parenteral bottle of synthetic resin
US5178607A (en) * 1987-07-31 1993-01-12 Lynn Lawrence A Blood aspiration assembly septum and blunt needle aspirator
US5211638A (en) * 1988-01-25 1993-05-18 Baxter International Inc. Pre-slit injection site
US5061263A (en) * 1989-02-13 1991-10-29 Terumo Kabushiki Kaisha Liquid collection tube
US5104379A (en) * 1989-04-03 1992-04-14 Olympus Optical Co., Ltd. Medical instrument and valve to be mounted on a mount piece of that instrument
US4985033A (en) * 1989-05-12 1991-01-15 Richard Wolf Gmbh Apparatus for fixing fascial holding sutures in open laparoscopy
US5137529A (en) * 1990-02-20 1992-08-11 Pudenz-Schulte Medical Research Corporation Injection port
US5490848A (en) * 1991-01-29 1996-02-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration System for creating on site, remote from a sterile environment, parenteral solutions
US5342316A (en) * 1991-02-14 1994-08-30 Wallace Henry G Resealable sampling port
US5211634A (en) * 1991-08-06 1993-05-18 Vaillancourt Vincent L Composite seal structure and a coupling arrangement for a cannula
US5425528A (en) * 1991-10-18 1995-06-20 Vetrisystems, Inc. Fluid dispensing apparatus
US5611792A (en) * 1992-04-12 1997-03-18 Dicamed Ab Value device for aseptic injection and removal of a medical fluid into/from a container
US5433716A (en) * 1992-05-13 1995-07-18 Heisenberg Finance S.A. Safety closing device for biological liquid containers
US5303838A (en) * 1992-09-30 1994-04-19 Portola Packaging, Inc. Frangible fitment for container
US5405333A (en) * 1992-12-28 1995-04-11 Richmond; Frank M. Liquid medicament bag with needleless connector fitting using boat assembly
US5395365A (en) * 1993-03-22 1995-03-07 Automatic Liquid Packaging, Inc. Container with pierceable and/or collapsible features
US5540674A (en) * 1993-09-28 1996-07-30 Abbott Laboratories Solution container with dual use access port
US6234335B1 (en) * 1994-12-05 2001-05-22 Integrated Liner Technologies Inc. Sealable container and open top cap with directly bonded elastomer septum
US5637107A (en) * 1994-12-29 1997-06-10 Vaillancourt; Vincent L. Sterilized vial closure and a sterilized parenteral vial
US6129228A (en) * 1995-01-30 2000-10-10 Portola Packaging, Inc. Apparatus and method for transporting fitment and fitment therefor
US5685845A (en) * 1995-07-11 1997-11-11 Becton, Dickinson And Company Sterile resealable vial connector assembly
US5718682A (en) * 1996-06-28 1998-02-17 United States Surgical Corporation Access port device and method of manufacture
US6090282A (en) * 1997-02-17 2000-07-18 Claber S.P.A. Filtering element for hose fittings of irrigation system, in particular but not exclusively for garden or kitchen garden
US6426046B1 (en) * 1997-12-08 2002-07-30 Mettler-Toledo Myriad, Ltd. Chemical vessel cap
US6113583A (en) * 1998-09-15 2000-09-05 Baxter International Inc. Vial connecting device for a sliding reconstitution device for a diluent container
US6200300B1 (en) * 1998-11-18 2001-03-13 David S. Smith Packaging Limited Hangable container
US6287293B1 (en) * 1999-09-28 2001-09-11 C. R. Bard, Inc. Method and apparatus for locating the injection point of an implanted medical device

Cited By (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7770611B2 (en) 1999-11-12 2010-08-10 Baxter International Inc. Peelable seal closure assembly
US8562583B2 (en) 2002-03-26 2013-10-22 Carmel Pharma Ab Method and assembly for fluid transfer and drug containment in an infusion system
US10123938B2 (en) 2002-03-26 2018-11-13 Carmel Pharma Ab Method and assembly for fluid transfer and drug containment in an infusion system
US10806668B2 (en) 2002-03-26 2020-10-20 Carmel Pharma Ab Method and assembly for fluid transfer and drug containment in an infusion system
US7867215B2 (en) 2002-04-17 2011-01-11 Carmel Pharma Ab Method and device for fluid transfer in an infusion system
US9039672B2 (en) 2002-07-09 2015-05-26 Carmel Pharma Ab Coupling component for transmitting medical substances
US8545475B2 (en) 2002-07-09 2013-10-01 Carmel Pharma Ab Coupling component for transmitting medical substances
US8328772B2 (en) 2003-01-21 2012-12-11 Carmel Pharma Ab Needle for penetrating a membrane
CN101044069B (en) * 2004-10-20 2010-08-25 费森尤斯卡比德国有限公司 Closing cap for containers filled with medical liquids
WO2006042579A1 (en) * 2004-10-20 2006-04-27 Fresenius Kabi Deutschland Gmbh Closing cap for containers filled with medical liquids
US20090054865A1 (en) * 2004-10-20 2009-02-26 Torsten Brandenburger Closing cap for containers filled with medical liquids
US8211081B2 (en) 2004-10-20 2012-07-03 Fresenius Kabi Deutschland Gmbh Closing cap for containers filled with medical liquids
EA009498B1 (en) * 2004-10-20 2008-02-28 Фрезениус Каби Дойчланд Гмбх Closing cap for containers filled with medical liquids
EP1721595B2 (en) 2005-05-13 2021-08-11 B. Braun Avitum AG Container for providing medical fluids
US9364246B2 (en) 2005-09-07 2016-06-14 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9179928B2 (en) 2005-09-07 2015-11-10 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US9272124B2 (en) 2005-12-02 2016-03-01 Ulthera, Inc. Systems and devices for selective cell lysis and methods of using same
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
US7942860B2 (en) 2007-03-16 2011-05-17 Carmel Pharma Ab Piercing member protection device
US8381776B2 (en) 2007-03-16 2013-02-26 Carmel Pharma Ab Piercing member protection device
US7975733B2 (en) 2007-05-08 2011-07-12 Carmel Pharma Ab Fluid transfer device
US8225826B2 (en) 2007-05-08 2012-07-24 Carmel Pharma Ab Fluid transfer device
US9309020B2 (en) 2007-06-13 2016-04-12 Carmel Pharma Ab Device for providing fluid to a receptacle
US8029747B2 (en) 2007-06-13 2011-10-04 Carmel Pharma Ab Pressure equalizing device, receptacle and method
US8622985B2 (en) 2007-06-13 2014-01-07 Carmel Pharma Ab Arrangement for use with a medical device
US8657803B2 (en) 2007-06-13 2014-02-25 Carmel Pharma Ab Device for providing fluid to a receptacle
US11071818B2 (en) 2007-08-30 2021-07-27 Carmel Pharma Ab Device, sealing member and fluid container
US10398834B2 (en) 2007-08-30 2019-09-03 Carmel Pharma Ab Device, sealing member and fluid container
US8287513B2 (en) 2007-09-11 2012-10-16 Carmel Pharma Ab Piercing member protection device
US8926583B2 (en) 2007-09-11 2015-01-06 Carmel Pharma Ab Piercing member protection device
US20100249745A1 (en) * 2007-09-17 2010-09-30 Carmel Pharma Ab Bag connector
US8827978B2 (en) * 2007-09-17 2014-09-09 Carmel Pharma Ab Bag connector
WO2009038505A1 (en) * 2007-09-17 2009-03-26 Carmel Pharma Ab Bag connector
US10220122B2 (en) 2007-10-09 2019-03-05 Ulthera, Inc. System for tissue dissection and aspiration
US9039722B2 (en) 2007-10-09 2015-05-26 Ulthera, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
US20090105684A1 (en) * 2007-10-23 2009-04-23 Baxter International Inc. Medication port for medical fluid container
WO2009055336A1 (en) 2007-10-23 2009-04-30 Baxter International Inc. Medication port for medical fluid container
US8075550B2 (en) 2008-07-01 2011-12-13 Carmel Pharma Ab Piercing member protection device
US8790330B2 (en) 2008-12-15 2014-07-29 Carmel Pharma Ab Connection arrangement and method for connecting a medical device to the improved connection arrangement
US8523838B2 (en) 2008-12-15 2013-09-03 Carmel Pharma Ab Connector device
US20100237163A1 (en) * 2009-03-23 2010-09-23 Cabochon Aesthetics, Inc. Bubble generator having disposable bubble cartridges
WO2010110932A1 (en) * 2009-03-23 2010-09-30 Cabochon Aesthetics, Inc. Bubble generator and method having disposable bubble cartridges
US8167280B2 (en) 2009-03-23 2012-05-01 Cabochon Aesthetics, Inc. Bubble generator having disposable bubble cartridges
US11337725B2 (en) 2009-08-07 2022-05-24 Ulthera, Inc. Handpieces for tissue treatment
US10531888B2 (en) 2009-08-07 2020-01-14 Ulthera, Inc. Methods for efficiently reducing the appearance of cellulite
US8894678B2 (en) 2009-08-07 2014-11-25 Ulthera, Inc. Cellulite treatment methods
US10485573B2 (en) 2009-08-07 2019-11-26 Ulthera, Inc. Handpieces for tissue treatment
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
US8906054B2 (en) 2009-08-07 2014-12-09 Ulthera, Inc. Apparatus for reducing the appearance of cellulite
US9510849B2 (en) 2009-08-07 2016-12-06 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9757145B2 (en) 2009-08-07 2017-09-12 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US8979881B2 (en) 2009-08-07 2015-03-17 Ulthera, Inc. Methods and handpiece for use in tissue dissection
US9044259B2 (en) 2009-08-07 2015-06-02 Ulthera, Inc. Methods for dissection of subcutaneous tissue
US8900262B2 (en) 2009-08-07 2014-12-02 Ulthera, Inc. Device for dissection of subcutaneous tissue
US10271866B2 (en) 2009-08-07 2019-04-30 Ulthera, Inc. Modular systems for treating tissue
US9078688B2 (en) 2009-08-07 2015-07-14 Ulthera, Inc. Handpiece for use in tissue dissection
US8900261B2 (en) 2009-08-07 2014-12-02 Ulthera, Inc. Tissue treatment system for reducing the appearance of cellulite
US8920452B2 (en) 2009-08-07 2014-12-30 Ulthera, Inc. Methods of tissue release to reduce the appearance of cellulite
USD637713S1 (en) 2009-11-20 2011-05-10 Carmel Pharma Ab Medical device adaptor
US8480646B2 (en) 2009-11-20 2013-07-09 Carmel Pharma Ab Medical device connector
US8162013B2 (en) 2010-05-21 2012-04-24 Tobias Rosenquist Connectors for fluid containers
US8336587B2 (en) 2010-05-21 2012-12-25 Carmel Pharma Ab Connectors for fluid containers
US9168203B2 (en) 2010-05-21 2015-10-27 Carmel Pharma Ab Connectors for fluid containers
US10603066B2 (en) 2010-05-25 2020-03-31 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US11213618B2 (en) 2010-12-22 2022-01-04 Ulthera, Inc. System for tissue dissection and aspiration
CN110664019A (en) * 2015-02-13 2020-01-10 方特慕控股第一私人有限公司 Filling system for an electronic smoking device
US20210251428A1 (en) * 2016-12-16 2021-08-19 Steven Pippin Apparatus and method for introducing a liquid into a sealed food package
US11653682B2 (en) * 2016-12-16 2023-05-23 Steven Pippin Apparatus and method for introducing a liquid into a sealed food package
US11291805B2 (en) 2017-02-10 2022-04-05 Terumo Kabushiki Kaisha Medical elongated body and medical elongated body set
RU176559U1 (en) * 2017-05-29 2018-01-23 Иностранное производственное унитарное предприятие "АЛКОПАК" Cap for containers filled with medical fluids
US20210315774A1 (en) * 2018-08-22 2021-10-14 Sartorius Stedim Biotech Gmbh Disposable port device for connecting a functional unit to a flexible wall of a disposable container and method of manufacturing a disposable port device
FR3085117A1 (en) * 2018-08-22 2020-02-28 Sartorius Stedim Biotech Gmbh Disposable port device for connecting a functional unit to a flexible wall of a disposable container and method of manufacturing a disposable port device
WO2020038811A1 (en) * 2018-08-22 2020-02-27 Sartorius Stedim Biotech Gmbh Disposable port device for connecting a functional unit to a flexible wall of a disposable container and method of manufacturing a disposable port device
CN114430701A (en) * 2019-09-23 2022-05-03 塞弗德公司 Multi-chamber lid device with reagent ports

Also Published As

Publication number Publication date
EP2545893A3 (en) 2013-03-06
EP1515678A1 (en) 2005-03-23
MXPA04011688A (en) 2005-03-31
CN1658814A (en) 2005-08-24
BR0311694A (en) 2007-05-08
HK1080353B (en) 2007-10-12
EP2545893A2 (en) 2013-01-16
JP2009189861A (en) 2009-08-27
HK1080353A1 (en) 2006-04-28
JP2005529685A (en) 2005-10-06
AU2003237274A1 (en) 2003-12-31
US6994699B2 (en) 2006-02-07
WO2003105748A1 (en) 2003-12-24
CN1320875C (en) 2007-06-13
CA2486212C (en) 2009-05-12
AU2003237274B2 (en) 2007-06-07
CA2486212A1 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
US6994699B2 (en) Port, a container and a method for accessing a port
JP2005529685A5 (en)
US5498253A (en) Port adaptor and protector and container having same
US6692478B1 (en) Swabbable needleless vial access
EP2621450B1 (en) Two-piece vial transfer needle assembly
JP6942230B2 (en) Disposable pen needle with shortened non-patient side end, and reusable pen interface
US4981464A (en) Plug device for a transfusible fluid container
CA2071280A1 (en) Transfer adaptors
KR980008252A (en) Syringe Filling and Carrying Device
JP2009536085A (en) Vented infusion access device
EP3562753B1 (en) Container closure operated by a connecting device
EP3562752B1 (en) Container closure operated by rotation
JP3294537B2 (en) Fluid transfer device for accessing fluid from vials and ampules and method for transferring fluid using the device
US20060089606A1 (en) Medicine-adding port of vein infusion set and catheter needle set

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAXTER INTERNATIONAL INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOUWAERT, VINCENT;MOTTA, DENIS;BALTEAU, PATRICK;AND OTHERS;REEL/FRAME:013310/0644;SIGNING DATES FROM 20020806 TO 20020828

AS Assignment

Owner name: BAXTER INTERNATIONAL INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAXTER INTERNATIONAL INC.;REEL/FRAME:013615/0736

Effective date: 20021218

Owner name: BAXTER HEALTHCARE S.A., SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAXTER INTERNATIONAL INC.;REEL/FRAME:013615/0736

Effective date: 20021218

AS Assignment

Owner name: BAXTER INTERNATIONAL, INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAXTER INTERNATIONAL, INC.;REEL/FRAME:014517/0927

Effective date: 20021218

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.)

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.)

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20180207